Modeling a complex disease: Multiple sclerosis

Advances in Immunology

Volumn 110, Issue , 2011, Pages 111-137

  Kurschus, Florian C ^a   Wörtge, Simone ^a   Waisman, Ari ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Animal Model; Autoimmunity; EAE; Multiple Sclerosis; Neurodegeneration

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; CD11B ANTIGEN; CRE RECOMBINASE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RAG1 PROTEIN; STAT1 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BOOK; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HELPER CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LEUKODYSTROPHY; MULTIPLE SCLEROSIS; MYELIN DEFICIENCY; MYELINATION; MYELOOPTIC NEUROPATHY; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; REMYELINIZATION; TH1 CELL; TH17 CELL;

EID: 79960232996     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387663-8.00001-6     Document Type: Chapter

References (147)

1. Adelmann M., Wood J., Benzel I., Fiori P., Lassmann H., Matthieu J.M., Gardinier M.V., Dornmair K., Linington C. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 1995, 63:17.
2. Al-Izki S., Pryce G., Jackson S.J., Giovannoni G., Baker D. Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis. Mult. Scler. 2011.
3. Anderson T.J., Schneider A., Barrie J.A., Klugmann M., McCulloch M.C., Kirkham D., Kyriakides E., Nave K.A., Griffiths I.R. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J. Comp. Neurol. 1998, 394:506.
4. Axtell R.C., Xu L., Barnum S.R., Raman C. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: Protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J. Immunol. 2006, 177:8542.
5. Axtell R.C., de Jong B.A., Boniface K., van der Voort L.F., Bhat R., De Sarno P., Naves R., Han M., Zhong F., Castellanos J.G., Mair R., Christakos A., et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010, 16:406.
6. Babbe H., Roers A., Waisman A., Lassmann H., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000, 192:393.
7. Baes M., Dewerchin M., Janssen A., Collen D., Carmeliet P. Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomes. Genesis 2002, 32:177.
8. Bankhurst A.D., Torrigiani G., Allison A.C. Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet 1973, 1:226.
9. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458.
10. Barnett M.H., Sutton I. The pathology of multiple sclerosis: A paradigm shift. Curr. Opin. Neurol. 2006, 19:242.
11. Becher B., Durell B.G., Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 2002, 110:493.
12. Ben-Nun A., Wekerle H., Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 1981, 11:195.
13. Ben-Nun A., Wekerle H., Cohen I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 1981, 292:60.
14. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003, 197:1073.
15. Bettelli E., Sullivan B., Szabo S.J., Sobel R.A., Glimcher L.H., Kuchroo V.K. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 2004, 200:79.
16. Bettelli E., Baeten D., Jager A., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 2006, 116:2393.
17. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235.
18. Blakemore W.F., Franklin R.J. Remyelination in experimental models of toxin-induced demyelination. Curr. Top. Microbiol. Immunol. 2008, 318:193.
19. Bradl M., Lassmann H. Oligodendrocytes: Biology and pathology. Acta Neuropathol. 2010, 119:37.
20. Bradl M., Misu T., Takahashi T., Watanabe M., Mader S., Reindl M., Adzemovic M., Bauer J., Berger T., Fujihara K., Itoyama Y., Lassmann H. Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009, 66:630.
21. Brockschnieder D., Lappe-Siefke C., Goebbels S., Boesl M.R., Nave K.A., Riethmacher D. Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination. Mol. Cell. Biol. 2004, 24:7636.
22. Buch T., Heppner F.L., Tertilt C., Heinen T.J., Kremer M., Wunderlich F.T., Jung S., Waisman A. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2005, 2:419.
23. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., Thompson W.J., Barres B.A. A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J. Neurosci. 2008, 28:264.
24. Cao Y., Toben C., Na S.Y., Stark K., Nitschke L., Peterson A., Gold R., Schimpl A., Hunig T. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur. J. Immunol. 2006, 36:207.
25. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560.
26. Compston A., Lassmann H., McDonald I. The story of multiple sclerosis. McAlpine's multiple sclerosis 2006, Churchill Livingston Elsevier, Amsterdam, Netherlands. A. Compston (Ed.).
27. Coquet J.M., Chakravarti S., Smyth M.J., Godfrey D.I. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 2008, 180:7097.
28. Croxford A.L., Kurschus F.C., Waisman A. Cutting edge: An IL-17F-CreEYFP reporter mouse allows fate mapping of Th17 cells. J. Immunol. 2009, 182:1237.
29. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744.
30. de Rosbo N.K., Kaye J.F., Eisenstein M., Mendel I., Hoeftberger R., Lassmann H., Milo R., Ben-Nun A. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 2004, 173:1426.
31. Doerflinger N.H., Macklin W.B., Popko B. Inducible site-specific recombination in myelinating cells. Genesis 2003, 35:63.
32. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252.
33. Einstein E.R., Robertson D.M., Dicaprio J.M., Moore W. The isolation from bovine spinal cord of a homogeneous protein with encephalitogenic activity. J. Neurochem. 1962, 9:353.
34. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568.
35. Elhofy A., Depaolo R.W., Lira S.A., Lukacs N.W., Karpus W.J. Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2009, 213:91.
36. Elliott J.I., Douek D.C., Altmann D.M. Mice lacking alpha beta + T cells are resistant to the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1996, 70:139.
37. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996, 156:5.
38. Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010, 162:1.
39. Ford M.L., Evavold B.D. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2005, 35:76.
40. Friese M.A., Jensen L.T., Willcox N., Fugger L. Humanized mouse models for organ-specific autoimmune diseases. Curr. Opin. Immunol. 2006, 18:704.
41. Friese M.A., Jakobsen K.B., Friis L., Etzensperger R., Craner M.J., McMahon R.M., Jensen L.T., Huygelen V., Jones E.Y., Bell J.I., Fugger L. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat. Med. 2008, 14:1227.
42. Furtado G.C., Olivares-Villagomez D., Curotto de Lafaille M.A., Wensky A.K., Latkowski J.A., Lafaille J.J. Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol. Rev. 2001, 182:122.
43. Furuzawa-Carballeda J., Vargas-Rojas M.I., Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 2007, 6:169.
44. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., Ramos H.L., Wei L., Davidson T.S., Bouladoux N., Grainger J.R., Chen Q., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967.
45. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., Murphy P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202:1087.
46. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993, 72:551.
47. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 2002, 169:7104.
48. Gyulveszi G., Haak S., Becher B. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Eur. J. Immunol. 2009, 39:1864.
49. Haak S., Croxford A.L., Kreymborg K., Heppner F.L., Pouly S., Becher B., Waisman A. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009, 119:61.
50. Hampton D.W., Anderson J., Pryce G., Irvine K.A., Giovannoni G., Fawcett J.W., Compston A., Franklin R.J., Baker D., Chandran S. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J. Neuroimmunol. 2008, 201-202:200.
51. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123.
52. Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., Ahlfors H., Wilhelm C., Tolaini M., Menzel U., Garefalaki A., Potocnik A.J., Stockinger B. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 2011, 12:255.
53. Holz A., Bielekova B., Martin R., Oldstone M.B. Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis. J. Immunol. 2000, 164:1103.
54. Hovelmeyer N., Hao Z., Kranidioti K., Kassiotis G., Buch T., Frommer F., von Hoch L., Kramer D., Minichiello L., Kollias G., Lassmann H., Waisman A. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175:5875.
55. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 2001, 194:669.
56. Ip C.W., Kroner A., Bendszus M., Leder C., Kobsar I., Fischer S., Wiendl H., Nave K.A., Martini R. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J. Neurosci. 2006, 26:8206.
57. Ivanov I.I., Littman D.R. Segmented filamentous bacteria take the stage. Mucosal Immunol. 2010, 3:209.
58. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121.
59. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., Tanoue T., Imaoka A., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485.
60. Ivanova A., Signore M., Caro N., Greene N.D., Copp A.J., Martinez-Barbera J.P. In vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment A. Genesis 2005, 43:129.
61. Kabat E.A., Wolf A., Bezer A.E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. Exp. Med. 1947, 85:117.
62. Kassmann C.M., Lappe-Siefke C., Baes M., Brugger B., Mildner A., Werner H.B., Natt O., Michaelis T., Prinz M., Frahm J., Nave K.A. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 2007, 39:969.
63. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human T(H)17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173.
64. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., Duquette P., Prat A. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 2009, 66:390.
65. Klugmann M., Schwab M.H., Puhlhofer A., Schneider A., Zimmermann F., Griffiths I.R., Nave K.A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 1997, 18:59.
66. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 1992, 256:1210.
67. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485.
68. Krishnamoorthy G., Lassmann H., Wekerle H., Holz A. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 2006, 116:2385.
69. Krishnamoorthy G., Saxena A., Mars L.T., Domingues H.S., Mentele R., Ben-Nun A., Lassmann H., Dornmair K., Kurschus F.C., Liblau R.S., Wekerle H. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat. Med. 2009, 15:626.
70. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008, 205:1535.
71. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., Kalled S.L., Hess D.M., Serafini B., Aloisi F., Wekerle H., Hohlfeld R., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 2005, 201:195.
72. Kurschus F.C., Croxford A.L., Heinen A.P., Wortge S., Ielo D., Waisman A. Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 2010, 40:3336.
73. Lafaille J.J., Nagashima K., Katsuki M., Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78:399.
74. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233.
75. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003, 33:366.
76. Lassmann H., Brunner C., Bradl M., Linington C. Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. 1988, 75:566.
77. Lazarevic V., Chen X., Shim J.H., Hwang E.S., Jang E., Bolm A.N., Oukka M., Kuchroo V.K., Glimcher L.H. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 2011, 12:96.
78. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., Weaver C.T. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92.
79. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004, 364:2106.
80. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 2005, 202:473.
81. Leonard J.P., Waldburger K.E., Goldman S.J. Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Ann. NY Acad. Sci. 1996, 795:216.
82. Leone D.P., Genoud S., Atanasoski S., Grausenburger R., Berger P., Metzger D., Macklin W.B., Chambon P., Suter U. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol. Cell. Neurosci. 2003, 22:430.
83. Lexberg M.H., Taubner A., Forster A., Albrecht I., Richter A., Kamradt T., Radbruch A., Chang H.D. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 2008, 38:2654.
84. Li C., Tropak M.B., Gerlai R., Clapoff S., Abramow-Newerly W., Trapp B., Peterson A., Roder J. Myelination in the absence of myelin-associated glycoprotein. Nature 1994, 369:747.
85. Linington C., Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 1987, 17:61.
86. Litzenburger T., Fassler R., Bauer J., Lassmann H., Linington C., Wekerle H., Iglesias A. B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice. J. Exp. Med. 1998, 188:169.
87. Liu G.Y., Fairchild P.J., Smith R.M., Prowle J.R., Kioussis D., Wraith D.C. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 1995, 3:407.
88. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500.
89. Logtenberg T., Kroon A., Gmelig-Meyling F.H., Ballieux R.E. Antigen-specific activation of autoreactive B cells in normal human individuals. Eur. J. Immunol. 1986, 16:1497.
90. Lucchinetti C.F., Bruck W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 1996, 6:259.
91. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707.
92. Määttä J.A., Kaldman M.S., Sakoda S., Salmi A.A., Hinkkanen A.E. Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase for BALB/c and SJL mice. Immunology 1998, 95:383.
93. Madsen L.S., Andersson E.C., Jansson L., Andersen C.B., Engberg J., Strominger J.L., Svejgaard A., Hjorth J.P., Holmdahl R., Wucherpfennig K.W., Fugger L. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 1999, 23:343.
94. Marignier R., Giraudon P., Vukusic S., Confavreux C., Honnorat J. Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: Therapeutic implications. Ther. Adv. Neurol. Disord. 2010, 3:311.
95. Mars L.T., Bauer J., Gross D.A., Bucciarelli F., Firat H., Hudrisier D., Lemonnier F., Kosmatopoulos K., Liblau R.S. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J. Immunol. 2007, 179:5090.
96. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., Tanuma N. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 1998, 28:1681.
97. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107.
98. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390.
99. Meier C., Bischoff A. Oligodendroglial cell development in jimpy mice and controls. An electron-microscopic study in the optic nerve. J. Neurol. Sci. 1975, 26:517.
100. Mendel I., Kerlero de Rosbo N., Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 1995, 25:1951.
101. Morgan I.M. Allergic encephalomyelitis in monkeys in response to injection of normal monkey cord. J. Bakteriol. 1946, 51:614.
102. Morris-Downes M.M., McCormack K., Baker D., Sivaprasad D., Natkunarajah J., Amor S. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 2002, 122:20.
103. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348.
104. Na S.Y., Cao Y., Toben C., Nitschke L., Stadelmann C., Gold R., Schimpl A., Hunig T. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 2008, 131:2353.
105. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244.
106. Nave K.A. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 2010, 11:275.
107. Nave K.A., Trapp B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 2008, 31:535.
108. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480.
109. Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 1998, 188:1883.
110. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715.
111. Pedotti R., De Voss J.J., Steinman L., Galli S.J. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 2003, 24:479.
112. Petermann F., Rothhammer V., Claussen M.C., Haas J.D., Blanco L.R., Heink S., Prinz I., Hemmer B., Kuchroo V.K., Oukka M., Korn T. Gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 2010, 33:351.
113. Pohl H.B., Porcheri C., Mueggler T., Bachmann L.C., Martino G., Riethmacher D., Franklin R.J., Rudin M., Suter U. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J. Neurosci. 2011, 31:1069.
114. Pöllinger B., Krishnamoorthy G., Berer K., Lassmann H., Bosl M.R., Dunn R., Domingues H.S., Holz A., Kurschus F.C., Wekerle H. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 2009, 206:1303.
115. Rajan A.J., Gao Y.L., Raine C.S., Brosnan C.F. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 1996, 157:941.
116. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514.
117. Rivers T.M., Sprunt D.H., Berry G.P. Observations on attempts to produce acute encephalomyelitis in monkeys. J. Exp. Med. 1933, 58:39.
118. Rosenbluth J. Central myelin in the mouse mutant shiverer. J. Comp. Neurol. 1980, 194:639.
119. Saadoun S., Waters P., Bell B.A., Vincent A., Verkman A.S., Papadopoulos M.C. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133:349.
120. Saxena A., Bauer J., Scheikl T., Zappulla J., Audebert M., Desbois S., Waisman A., Lassmann H., Liblau R.S., Mars L.T. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 2008, 181:1617.
121. Segal B.M. Getting to the crux of the matter: IL-23 and Th17 cell accumulation in the CNS. Eur. J. Immunol. 2009, 39:1713.
122. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007, 204:2899.
123. Siffrin V., Radbruch H., Glumm R., Niesner R., Paterka M., Herz J., Leuenberger T., Lehmann S.M., Luenstedt S., Rinnenthal J.L., Laube G., Luche H., et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 2010, 33:424.
124. Slavin A., Kelly-Modis L., Labadia M., Ryan K., Brown M.L. Pathogenic mechanisms and experimental models of multiple sclerosis. Autoimmunity 2010, 43:504.
125. Sobottka B., Harrer M.D., Ziegler U., Fischer K., Wiendl H., Hunig T., Becher B., Goebels N. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am. J. Pathol. 2009, 175:1160.
126. Sonderegger I., Kisielow J., Meier R., King C., Kopf M. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 2008, 38:1833.
127. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 2001, 194:F27.
128. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008, 14:337.
129. Stuart G., Krikorian K.S. The neuro-paralytic accidents of anti-rabies treatment. Ann. Trop. Med. Parasitol. 1928, 22:327.
130. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001, 166:7579.
131. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331.
132. Timsit S.G., Bally-Cuif L., Colman D.R., Zalc B. DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J. Neurochem. 1992, 58:1172.
133. Timsit S., Martinez S., Allinquant B., Peyron F., Puelles L., Zalc B. Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 mRNA expression. J. Neurosci. 1995, 15:1012.
134. Traka M., Arasi K., Avila R.L., Podojil J.R., Christakos A., Miller S.D., Soliven B., Popko B. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 2010, 133:3017.
135. Trapp B.D., Nave K.A. Multiple sclerosis: An immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247.
136. Trifilo M.J., Bergmann C.C., Kuziel W.A., Lane T.E. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J. Virol. 2003, 77:4004.
137. Van de Keere F., Tonegawa S. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 1998, 188:1875.
138. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179.
139. Waldner H., Whitters M.J., Sobel R.A., Collins M., Kuchroo V.K. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. USA 2000, 97:3412.
140. Wekerle H., Kurschus F.C. Animal models of multiple sclerosis. Drug Discov. Today Dis. Models 2006, 3:359.
141. Werner H., Jung M., Klugmann M., Sereda M., Griffiths I.R., Nave K.A. Mouse models of myelin diseases. Brain Pathol. 1998, 8:771.
142. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996, 157:3223.
143. Wucherpfennig K.W., Newcombe J., Li H., Keddy C., Cuzner M.L., Hafler D.A. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 1992, 175:993.
144. Yin X., Crawford T.O., Griffin J.W., Tu P., Lee V.M., Li C., Roder J., Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 1998, 18:1953.
145. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990, 8:579.
146. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., Steinman L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985, 317:355.
147. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646.